(+)-pilocarpine multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Pilocarpine results in increased expression of LAMP2 protein] CTD PMID:19272430 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of LAMP2 mRNA, Pilocarpine results in increased expression of LAMP2 protein CTD PMID:19272430 (1->4)-beta-D-glucan multiple interactions ISO RGD:10857 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LAMP2 mRNA CTD PMID:36331819 (S)-nicotine decreases expression ISO RGD:735952 6480464 Nicotine results in decreased expression of LAMP2 protein CTD PMID:33010382 1,2-dimethylhydrazine decreases expression ISO RGD:10857 6480464 1, 2-Dimethylhydrazine results in decreased expression of LAMP2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:10857 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LAMP2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:735952 6480464 Dinitrochlorobenzene binds to LAMP2 protein CTD PMID:32991956 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of LAMP2 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:10857 6480464 Ethinyl Estradiol affects the expression of LAMP2 mRNA CTD PMID:17555576 17beta-estradiol affects expression ISO RGD:10857 6480464 Estradiol affects the expression of LAMP2 mRNA CTD PMID:15598610 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10857 6480464 Tetrachlorodibenzodioxin results in decreased expression of LAMP2 mRNA CTD PMID:19770486 , PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LAMP2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LAMP2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10857 6480464 Tetrachlorodibenzodioxin affects the expression of LAMP2 mRNA CTD PMID:21570461 3,4-methylenedioxymethamphetamine increases expression ISO RGD:735952 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of LAMP2 protein CTD PMID:32186374 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of LAMP2 protein CTD PMID:32186374 3-methyladenine multiple interactions ISO RGD:735952 6480464 3-methyladenine inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein] CTD PMID:31226464 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of LAMP2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:10857 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LAMP2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases methylation ISO RGD:10857 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of LAMP2 exon CTD PMID:33297965 aflatoxin B1 decreases expression ISO RGD:10857 6480464 Aflatoxin B1 results in decreased expression of LAMP2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:735952 6480464 Aflatoxin B1 results in decreased methylation of LAMP2 gene CTD PMID:27153756 aldehydo-D-glucose multiple interactions ISO RGD:735952 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of LAMP2 protein CTD PMID:21392095 all-trans-retinoic acid multiple interactions ISO RGD:735952 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of LAMP2 mRNA] CTD PMID:16140955 all-trans-retinoic acid increases expression ISO RGD:735952 6480464 Tretinoin results in increased expression of LAMP2 mRNA CTD PMID:16140955 more ... aloxistatin multiple interactions ISO RGD:735952 6480464 [aloxistatin co-treated with pepstatin] results in increased expression of LAMP2 protein CTD PMID:32186374 alpha,alpha-trehalose multiple interactions ISO RGD:10857 6480464 TFEB affects the reaction [Trehalose results in increased expression of LAMP2 mRNA] CTD PMID:30335591 alpha,alpha-trehalose increases expression ISO RGD:10857 6480464 Trehalose results in increased expression of LAMP2 mRNA CTD PMID:30335591 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LAMP2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of LAMP2 mRNA CTD PMID:30779732 arachidonic acid decreases expression ISO RGD:10857 6480464 Arachidonic Acid results in decreased expression of LAMP2 mRNA CTD PMID:16623957 aristolochic acid A decreases expression ISO RGD:735952 6480464 aristolochic acid I results in decreased expression of LAMP2 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:10857 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of LAMP2 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO RGD:735952 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of LAMP2 protein CTD PMID:31781319 atrazine multiple interactions ISO RGD:735952 6480464 [Atrazine co-treated with Arsenates] results in increased expression of LAMP2 mRNA CTD PMID:18585445 atrazine increases expression ISO RGD:735952 6480464 Atrazine results in increased expression of LAMP2 mRNA CTD PMID:22378314 beauvericin multiple interactions ISO RGD:735952 6480464 [beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein CTD PMID:32407736 benzo[a]pyrene increases expression ISO RGD:10857 6480464 Benzo(a)pyrene results in increased expression of LAMP2 mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions ISO RGD:735952 6480464 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... CTD PMID:35487446 benzo[a]pyrene increases expression ISO RGD:735952 6480464 Benzo(a)pyrene results in increased expression of LAMP2 mRNA, Benzo(a)pyrene results in increased expression of LAMP2 protein CTD PMID:35487446 benzo[a]pyrene decreases expression ISO RGD:735952 6480464 Benzo(a)pyrene results in decreased expression of LAMP2 mRNA CTD PMID:34332006 benzo[a]pyrene increases methylation ISO RGD:735952 6480464 Benzo(a)pyrene results in increased methylation of LAMP2 exon, Benzo(a)pyrene results in increased methylation of LAMP2 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735952 6480464 7 more ... CTD PMID:20018196 bicalutamide increases expression ISO RGD:735952 6480464 bicalutamide results in increased expression of LAMP2 mRNA CTD PMID:16631469 bilirubin IXalpha decreases expression ISO RGD:735952 6480464 Bilirubin results in decreased expression of LAMP2 mRNA CTD PMID:20196124 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LAMP2 mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A decreases expression ISO RGD:735952 6480464 bisphenol A results in decreased expression of LAMP2 protein CTD PMID:34186270 bisphenol A multiple interactions ISO RGD:10857 6480464 coenzyme Q10 inhibits the reaction [bisphenol A results in decreased expression of LAMP2 protein] CTD PMID:34186417 bisphenol A multiple interactions ISO RGD:735952 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LAMP2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:10857 6480464 bisphenol A results in decreased expression of LAMP2 mRNA, bisphenol A results in decreased expression of LAMP2 protein CTD PMID:33221593 , PMID:34186417 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LAMP2 mRNA CTD PMID:30816183 Bisphenol B increases expression ISO RGD:735952 6480464 bisphenol B results in increased expression of LAMP2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:735952 6480464 bisphenol F results in increased expression of LAMP2 protein CTD PMID:34186270 Brusatol multiple interactions EXP 6480464 brusatol inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LAMP2 protein] CTD PMID:34695510 butanal decreases expression ISO RGD:735952 6480464 butyraldehyde results in decreased expression of LAMP2 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:10857 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMP2 protein CTD PMID:31862506 cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LAMP2 protein more ... CTD PMID:34695510 cadmium dichloride increases expression ISO RGD:10857 6480464 Cadmium Chloride results in increased expression of LAMP2 mRNA CTD PMID:30030080 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LAMP2 protein more ... CTD PMID:34695510 cadmium dichloride multiple interactions ISO RGD:10857 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMP2 protein CTD PMID:31862506 calciol increases expression ISO RGD:10857 6480464 Cholecalciferol results in increased expression of LAMP2 mRNA CTD PMID:16508948 carbamazepine multiple interactions EXP 6480464 [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of LAMP2 mRNA more ... CTD PMID:35786680 carbon nanotube increases expression ISO RGD:10857 6480464 Nanotubes more ... CTD PMID:24929217 , PMID:25554681 carnosic acid decreases expression ISO RGD:10857 6480464 salvin results in decreased expression of LAMP2 protein CTD PMID:35926579 chloroquine multiple interactions ISO RGD:735952 6480464 [quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of LAMP2 protein more ... CTD PMID:30821613 cisplatin increases expression ISO RGD:10857 6480464 Cisplatin results in increased expression of LAMP2 mRNA CTD PMID:21151649 clofibrate decreases expression ISO RGD:10857 6480464 Clofibrate results in decreased expression of LAMP2 mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LAMP2 mRNA CTD PMID:17602206 cobalt dichloride increases expression ISO RGD:735952 6480464 cobaltous chloride results in increased expression of LAMP2 mRNA CTD PMID:19376846 cocaine increases expression EXP 6480464 Cocaine results in increased expression of LAMP2 protein CTD PMID:25100957 coenzyme Q10 multiple interactions ISO RGD:10857 6480464 coenzyme Q10 inhibits the reaction [bisphenol A results in decreased expression of LAMP2 protein] CTD PMID:34186417 copper atom multiple interactions ISO RGD:735952 6480464 [NSC 689534 binds to Copper] which results in increased expression of LAMP2 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:735952 6480464 [NSC 689534 binds to Copper] which results in increased expression of LAMP2 mRNA CTD PMID:20971185 copper(II) chloride multiple interactions ISO RGD:10857 6480464 PP242 inhibits the reaction [cupric chloride results in decreased expression of LAMP2 mRNA] CTD PMID:32512069 copper(II) chloride decreases expression ISO RGD:10857 6480464 cupric chloride results in decreased expression of LAMP2 mRNA CTD PMID:32512069 corosolic acid multiple interactions ISO RGD:10857 6480464 corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein] CTD PMID:34296331 corosolic acid multiple interactions EXP 6480464 corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein], TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein]] CTD PMID:34296331 cyclosporin A decreases expression ISO RGD:10857 6480464 Cyclosporine results in decreased expression of LAMP2 mRNA CTD PMID:19770486 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of LAMP2 CTD PMID:25299210 D-glucose multiple interactions ISO RGD:735952 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of LAMP2 protein CTD PMID:21392095 dibutyl phthalate increases expression ISO RGD:10857 6480464 Dibutyl Phthalate results in increased expression of LAMP2 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:735952 6480464 dicrotophos results in decreased expression of LAMP2 mRNA CTD PMID:28302478 Didecyldimethylammonium decreases expression ISO RGD:735952 6480464 didecyldimethylammonium results in decreased expression of LAMP2 protein CTD PMID:32763356 dimethyl fumarate multiple interactions ISO RGD:10857 6480464 NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of LAMP2 protein alternative form] CTD PMID:29950142 dimethyl fumarate increases expression ISO RGD:10857 6480464 Dimethyl Fumarate results in increased expression of LAMP2 protein alternative form CTD PMID:29950142 dioxygen multiple interactions ISO RGD:735952 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of LAMP2 protein CTD PMID:21392095 dorsomorphin multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:735952 6480464 3-methyladenine inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein], PQQ Cofactor inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein] CTD PMID:31226464 doxorubicin multiple interactions EXP 6480464 corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein], TFEB protein promotes the reaction [corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein]] CTD PMID:34296331 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of LAMP2 protein CTD PMID:34296331 doxorubicin multiple interactions ISO RGD:10857 6480464 corosolic acid inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein] CTD PMID:34296331 doxorubicin decreases expression ISO RGD:10857 6480464 Doxorubicin results in decreased expression of LAMP2 protein CTD PMID:34296331 doxorubicin decreases expression ISO RGD:735952 6480464 Doxorubicin results in decreased expression of LAMP2 protein CTD PMID:31226464 enniatin multiple interactions ISO RGD:735952 6480464 [beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein CTD PMID:32407736 entinostat increases expression ISO RGD:735952 6480464 entinostat results in increased expression of LAMP2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA CTD PMID:27188386 enzyme inhibitor multiple interactions ISO RGD:735952 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LAMP2 protein CTD PMID:23301498 ethambutol increases expression EXP 6480464 Ethambutol results in increased expression of LAMP2 protein CTD PMID:19063910 ethambutol multiple interactions EXP 6480464 N more ... CTD PMID:19063910 ethanol decreases expression ISO RGD:10857 6480464 Ethanol results in decreased expression of LAMP2 protein CTD PMID:25460735 ethanol affects splicing ISO RGD:10857 6480464 Ethanol affects the splicing of LAMP2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:735952 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LAMP2 mRNA CTD PMID:29432896 ethanol increases expression ISO RGD:10857 6480464 Ethanol results in increased expression of LAMP2 mRNA CTD PMID:24492484 ferric oxide increases expression ISO RGD:10857 6480464 ferric oxide analog results in increased expression of LAMP2 protein CTD PMID:25086211 folic acid multiple interactions ISO RGD:10857 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LAMP2 mRNA CTD PMID:22206623 folic acid decreases expression ISO RGD:10857 6480464 Folic Acid results in decreased expression of LAMP2 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:735952 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LAMP2 gene CTD PMID:31601247 genistein multiple interactions ISO RGD:735952 6480464 ESR2 promotes the reaction [Genistein results in increased expression of LAMP2 protein] CTD PMID:20884965 genistein increases expression ISO RGD:735952 6480464 Genistein results in increased expression of LAMP2 protein CTD PMID:20884965 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LAMP2 mRNA CTD PMID:22061828 , PMID:33387578 glucose multiple interactions ISO RGD:735952 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of LAMP2 protein CTD PMID:21392095 hydrogen peroxide multiple interactions ISO RGD:10857 6480464 NFE2L2 protein affects the reaction [Hydrogen Peroxide results in increased expression of LAMP2 protein alternative form] CTD PMID:29950142 hydrogen peroxide increases expression ISO RGD:10857 6480464 Hydrogen Peroxide results in increased expression of LAMP2 protein alternative form CTD PMID:29950142 ivermectin decreases expression ISO RGD:735952 6480464 Ivermectin results in decreased expression of LAMP2 protein CTD PMID:32959892 lead nitrate increases expression ISO RGD:10857 6480464 lead nitrate results in increased expression of LAMP2 protein CTD PMID:23376802 lead(0) affects expression ISO RGD:735952 6480464 Lead affects the expression of LAMP2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:735952 6480464 Lead affects the expression of LAMP2 mRNA CTD PMID:28903495 lipopolysaccharide increases expression ISO RGD:10857 6480464 Lipopolysaccharides results in increased expression of LAMP2 protein CTD PMID:23376802 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of LAMP2 protein] CTD PMID:26882442 mercury dibromide increases expression ISO RGD:735952 6480464 mercuric bromide results in increased expression of LAMP2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA CTD PMID:27188386 methamphetamine affects localization EXP 6480464 Methamphetamine affects the localization of LAMP2 protein CTD PMID:17105920 methamphetamine increases expression ISO RGD:10857 6480464 Methamphetamine results in increased expression of LAMP2 mRNA, Methamphetamine results in increased expression of LAMP2 protein CTD PMID:35643125 methylisothiazolinone increases expression ISO RGD:735952 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of LAMP2 protein CTD PMID:29110394 methylmercury chloride increases expression ISO RGD:735952 6480464 methylmercuric chloride results in increased expression of LAMP2 mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA CTD PMID:27188386 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions EXP 6480464 N more ... CTD PMID:19063910 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:735952 6480464 N more ... CTD PMID:12888634 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:735952 6480464 1-Methyl-4-phenylpyridinium promotes the reaction [LRRK2 gene mutant form results in increased expression of LAMP2 protein] CTD PMID:25017139 N-methyl-4-phenylpyridinium increases expression ISO RGD:735952 6480464 1-Methyl-4-phenylpyridinium results in increased expression of LAMP2 protein CTD PMID:25017139 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LAMP2 mRNA CTD PMID:17602206 nicotine decreases expression ISO RGD:735952 6480464 Nicotine results in decreased expression of LAMP2 protein CTD PMID:33010382 Nivalenol increases expression ISO RGD:10857 6480464 nivalenol results in increased expression of LAMP2 mRNA CTD PMID:35016910 paclitaxel affects response to substance ISO RGD:735952 6480464 LAMP2 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 panobinostat increases expression ISO RGD:735952 6480464 panobinostat results in increased expression of LAMP2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:735952 6480464 Acetaminophen results in increased expression of LAMP2 mRNA CTD PMID:22230336 paraquat increases expression ISO RGD:10857 6480464 Paraquat results in increased expression of LAMP2 protein alternative form CTD PMID:29950142 paraquat multiple interactions ISO RGD:10857 6480464 NFE2L2 protein affects the reaction [Paraquat results in increased expression of LAMP2 protein alternative form] CTD PMID:29950142 pepstatin A multiple interactions ISO RGD:735952 6480464 [aloxistatin co-treated with pepstatin] results in increased expression of LAMP2 protein, [CA 074 methyl ester co-treated with pepstatin] results in increased expression of LAMP2 protein CTD PMID:32186374 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10857 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LAMP2 mRNA, PP242 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of LAMP2 protein] CTD PMID:32861759 , PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:10857 6480464 perfluorooctane sulfonic acid results in decreased expression of LAMP2 protein CTD PMID:32861759 phenylmercury acetate increases expression ISO RGD:735952 6480464 Phenylmercuric Acetate results in increased expression of LAMP2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA CTD PMID:27188386 potassium dichromate decreases expression ISO RGD:10857 6480464 Potassium Dichromate results in decreased expression of LAMP2 mRNA CTD PMID:23608068 Propiverine affects binding EXP 6480464 propiverine binds to LAMP2 protein CTD PMID:29273565 pyrogallol increases expression ISO RGD:10857 6480464 Pyrogallol results in increased expression of LAMP2 mRNA CTD PMID:20362636 pyrroloquinoline quinone multiple interactions ISO RGD:735952 6480464 PQQ Cofactor inhibits the reaction [Doxorubicin results in decreased expression of LAMP2 protein] CTD PMID:31226464 quizartinib multiple interactions ISO RGD:735952 6480464 [quizartinib co-treated with spautin-1 co-treated with Chloroquine] results in increased transport of and affects the localization of LAMP2 protein more ... CTD PMID:30821613 rimonabant multiple interactions ISO RGD:10857 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of LAMP2 mRNA] CTD PMID:19030233 rotenone increases expression ISO RGD:10857 6480464 Rotenone results in increased expression of LAMP2 mRNA CTD PMID:23186747 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of LAMP2 protein alternative form CTD PMID:29649621 rotenone multiple interactions ISO RGD:735952 6480464 PARK7 protein inhibits the reaction [Rotenone results in increased expression of LAMP2 protein alternative form] CTD PMID:29649621 sarin decreases expression ISO RGD:735952 6480464 Sarin results in decreased expression of LAMP2 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom increases expression ISO RGD:10857 6480464 Silver results in increased expression of LAMP2 protein CTD PMID:25458489 silver(0) increases expression ISO RGD:10857 6480464 Silver results in increased expression of LAMP2 protein CTD PMID:25458489 sodium arsenite increases expression ISO RGD:735952 6480464 sodium arsenite results in increased expression of LAMP2 mRNA CTD PMID:20816728 sodium arsenite multiple interactions ISO RGD:735952 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of LAMP2 protein CTD PMID:31781319 sodium fluoride decreases expression ISO RGD:10857 6480464 Sodium Fluoride results in decreased expression of LAMP2 protein CTD PMID:28918527 Soman increases expression EXP 6480464 Soman results in increased expression of LAMP2 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [[Dietary Fats co-treated with Carbamazepine] affects the susceptibility to Streptozocin] which results in decreased expression of LAMP2 mRNA more ... CTD PMID:35786680 sulforaphane increases expression ISO RGD:10857 6480464 sulforaphane results in increased expression of LAMP2 mRNA alternative form, sulforaphane results in increased expression of LAMP2 protein alternative form CTD PMID:29950142 sulforaphane multiple interactions ISO RGD:10857 6480464 NFE2L2 protein affects the reaction [sulforaphane results in increased expression of LAMP2 protein alternative form] CTD PMID:29950142 sulforaphane increases expression ISO RGD:735952 6480464 sulforaphane results in increased expression of LAMP2 mRNA alternative form, sulforaphane results in increased expression of LAMP2 protein alternative form CTD PMID:29950142 sunitinib increases expression ISO RGD:735952 6480464 Sunitinib results in increased expression of LAMP2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:10857 6480464 Tamoxifen affects the expression of LAMP2 mRNA CTD PMID:17555576 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LAMP2 protein CTD PMID:26882442 tetrachloromethane decreases expression ISO RGD:10857 6480464 Carbon Tetrachloride results in decreased expression of LAMP2 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of LAMP2 protein] CTD PMID:26882442 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of LAMP2 mRNA CTD PMID:34492290 thiophenes multiple interactions ISO RGD:735952 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of LAMP2 mRNA] CTD PMID:16140955 titanium dioxide increases expression ISO RGD:10857 6480464 titanium dioxide analog results in increased expression of LAMP2 protein CTD PMID:25111187 trichostatin A increases expression ISO RGD:735952 6480464 trichostatin A results in increased expression of LAMP2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA CTD PMID:27188386 trifloxystrobin increases expression ISO RGD:735952 6480464 trifloxystrobin results in increased expression of LAMP2 protein CTD PMID:27853101 triptonide increases expression ISO RGD:10857 6480464 triptonide results in increased expression of LAMP2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:10857 6480464 troglitazone results in decreased expression of LAMP2 mRNA CTD PMID:28973697 uranium atom affects expression ISO RGD:735952 6480464 Uranium affects the expression of LAMP2 mRNA CTD PMID:15672453 valproic acid increases expression ISO RGD:735952 6480464 Valproic Acid results in increased expression of LAMP2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:735952 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMP2 mRNA CTD PMID:27188386 vitamin E multiple interactions EXP 6480464 Vitamin E inhibits the reaction [Pilocarpine results in increased expression of LAMP2 protein] CTD PMID:19272430 zidovudine decreases expression EXP 6480464 Zidovudine results in decreased expression of LAMP2 protein CTD PMID:29594326 zinc oxide increases expression ISO RGD:735952 6480464 Zinc Oxide results in increased expression of LAMP2 protein CTD PMID:29289694